
Deninta SC Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Denosumab (60mg)
Overview Deninta SC Injection
Osteoporosis treatment in postmenopausal women and fracture-risk men is facilitated by Deninta SC Injection. This medication strengthens bones, lowering fracture probability. Administration is strictly by a healthcare provider; self-injection is prohibited. Consistent, daily dosing maximizes effectiveness; adhere to your doctor's prescribed regimen, completing the full course even with symptom improvement. Concurrent calcium and vitamin D supplementation enhances therapeutic benefit. Headache, limb pain, musculoskeletal and nerve pain, constipation, and rash are potential side effects. Persistent or worsening side effects warrant medical consultation; management strategies may be available. Prior to commencing treatment, disclose all other medications to your physician to ensure safety. Pregnant or breastfeeding individuals should seek medical counsel before using Deninta SC Injection.
Uses of Deninta SC Injection
Bone fragility
Major Benefits of Deninta SC Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Deninta SC Injection:
- Musculoskeletal (bone, muscle or joint) pain
- Pain in extremities
- Nerve pain
- Constipation
- Rash
- Headache
How to use Deninta SC Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Deninta SC Injection works:
The subcutaneous injection, Deninta, utilizes a monoclonal antibody to target a bone-resorbing protein. This action enhances bone strength and reduces fracture probability.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Deninta SC Injection alongside alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Deninta SC Injection during pregnancy carries substantial risk. Pregnant women should consult their physician before use, as research in both animals and pregnant humans indicates significant potential harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Deninta SC Injection while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Deninta SC Injection.
KidneyCAUTION
Individuals with severe renal impairment should exercise caution when using Deninta SC Injection. Dosage modification of Deninta SC Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Deninta SC Injection, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Deninta SC Injection :
Omit a scheduled Deninta SC Injection? Seek your physician's advice.
Facts to Know About Deninta SC Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
